Alphatec Holdings, Inc.
- Jurisdiction
United States - LEI
549300EZE8CQ8K65FS24 - ISIN
US02081G2012 (ATEC )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. Read full profile
Stock price
Fundamentals
- Net revenue
€585.36M - Gross margin
68.8% - EBIT
-€95.98M - EBIT margin
-16.4% - Net income
-€142.43M - Net margin
-24.3%
Statement period: - (published )
Dividends
No dividend payouts
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Miles Patrick | CEO |
|
|
|
|
Lish Scott | CHIEF OPERATING OFFICER |
|
|
|
|
Lish Scott | CHIEF OPERATING OFFICER |
|
|
|
|
Hunsaker Craig E | EVP, PEOPLE & CULTURE |
|
|
|
|
Lish Scott | CHIEF OPERATING OFFICER |
|
|
|
|
Earnings Calls
Latest earnings call: May 7, 2024
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |